0001209191-22-042002.txt : 20220713 0001209191-22-042002.hdr.sgml : 20220713 20220713101323 ACCESSION NUMBER: 0001209191-22-042002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220712 FILED AS OF DATE: 20220713 DATE AS OF CHANGE: 20220713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lundberg Sven Ante CENTRAL INDEX KEY: 0001682126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 221080350 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-12 0 0001651311 Merus N.V. MRUS 0001682126 Lundberg Sven Ante C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM NETHERLANDS 1 1 0 0 President, CEO & PFO Common Shares 2022-07-12 4 P 0 4340 22.9688 A 19340 D Sold in pursuant to 10B5-1 plan dated 6/10/22 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.75 to $23.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. /s/ Peter Silverman as attorney-in-fact 2022-07-13